Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC)

Abstract

T3 supplementation is safe. Analyses using age stratification indicate that T3 supplementation provides clinical advantages in patients younger than 5 months and no benefit for those older than 5 months. Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: NCT00027417.